These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31498141)

  • 21. [Correlation between cognitive impairment and postural instability in patients with Parkinson's disease].
    Owan Y; Murakami H; Mori Y; Yamagishi K; Watanabe D; Kato H; Kezuka M; Kawamura M
    Brain Nerve; 2015 Jan; 67(1):99-104. PubMed ID: 25585439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive and Motor Aspects of Parkinson's Disease Associated with Dysphagia.
    Kim JS; Youn J; Suh MK; Kim TE; Chin J; Park S; Cho JW
    Can J Neurol Sci; 2015 Nov; 42(6):395-400. PubMed ID: 26551089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can cognitive remediation improve mobility in patients with Parkinson's disease? Findings from a 12 week pilot study.
    Milman U; Atias H; Weiss A; Mirelman A; Hausdorff JM
    J Parkinsons Dis; 2014; 4(1):37-44. PubMed ID: 24322063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Computer-Based Cognitive Rehabilitation on Attention, Executive Functions, and Quality of Life in Patients with Parkinson's Disease: A Randomized, Controlled, Single-Blinded Pilot Study.
    Svaerke K; Faerk AK; Riis A; Stiegnitz von Ehrenfels SEM; Mogensen J; Lokkegaard A
    Dement Geriatr Cogn Disord; 2021; 50(6):519-528. PubMed ID: 34986487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive Remediation for Inpatients With Schizophrenia: Effects of a Brief and Intensive Training.
    Buonocore M; Agostoni G; Bechi M; Inguscio E; Gritti D; Anchora L; Spangaro M; Cocchi F; Bianchi L; Guglielmino C; Sormani M; Russotti M; Bosia M; Cavallaro R
    J Nerv Ment Dis; 2021 Jan; 209(1):76-81. PubMed ID: 33141786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of computer-based cognitive flexibility training on recovery of executive function after stroke: rationale, design and methods of the TAPASS study.
    van de Ven RM; Schmand B; Groet E; Veltman DJ; Murre JM
    BMC Neurol; 2015 Aug; 15():144. PubMed ID: 26286548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson's disease.
    van Balkom TD; Berendse HW; van der Werf YD; Twisk JWR; Zijlstra I; Hagen RH; Berk T; Vriend C; van den Heuvel OA
    BMC Neurol; 2019 Jul; 19(1):179. PubMed ID: 31366395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive rehabilitation in Parkinson's disease.
    Sinforiani E; Banchieri L; Zucchella C; Pacchetti C; Sandrini G
    Arch Gerontol Geriatr Suppl; 2004; (9):387-91. PubMed ID: 15207437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurorehabilitation in Parkinson's disease].
    Möller JC; Menig A; Oechsner M
    Praxis (Bern 1994); 2016 Mar; 105(7):377-82. PubMed ID: 27005731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor Speed Matters! Cognitive Profile of Parkinson's Disease Patients With and Without Deficits in Motor Speed.
    Menon V; Hegde S; Pratyusha PV; Kamble N; Yadav R; Bhattacharya A; Pal PK
    Neurol India; 2021; 69(3):604-608. PubMed ID: 34169851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurorehabilitation in Parkinson's Disease: A Critical Review of Cognitive Rehabilitation Effects on Cognition and Brain.
    Díez-Cirarda M; Ibarretxe-Bilbao N; Peña J; Ojeda N
    Neural Plast; 2018; 2018():2651918. PubMed ID: 29853840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease.
    Mao CJ; Wang F; Chen JP; Yang YP; Chen J; Huang JY; Liu CF
    Clin Interv Aging; 2017; 12():1637-1644. PubMed ID: 29070942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eight Weeks of Aerobic Interval Training Improves Psychomotor Function in Patients with Parkinson's Disease-Randomized Controlled Trial.
    Marusiak J; Fisher BE; Jaskólska A; Słotwiński K; Budrewicz S; Koszewicz M; Kisiel-Sajewicz K; Kamiński B; Jaskólski A
    Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30861998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive recovery in people with relapsing/remitting multiple sclerosis: A randomized clinical trial on virtual reality-based neurorehabilitation.
    Leonardi S; Maggio MG; Russo M; Bramanti A; Arcadi FA; Naro A; Calabrò RS; De Luca R
    Clin Neurol Neurosurg; 2021 Sep; 208():106828. PubMed ID: 34332269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cognitive training in Parkinson's disease: a randomized controlled trial.
    Petrelli A; Kaesberg S; Barbe MT; Timmermann L; Fink GR; Kessler J; Kalbe E
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1196-202. PubMed ID: 25242806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of cognitive reserve on the effectiveness of balance rehabilitation in Parkinson's disease.
    Piccinini G; Imbimbo I; Ricciardi D; Coraci D; Santilli C; Lo Monaco MR; Loreti C; Vulpiani MC; Silveri MC; Padua L
    Eur J Phys Rehabil Med; 2018 Aug; 54(4):554-559. PubMed ID: 29144106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of Cognitive Rehabilitation as a Balance Rehabilitation Strategy in Patients with Parkinson's Disease: Study Protocol for a Randomized Controlled Trial.
    Arroyo-Ferrer A; Sánchez-Cuesta FJ; González-Zamorano Y; Del Castillo MD; Sastre-Barrios C; Ríos-Lago M; Romero JP
    Medicina (Kaunas); 2021 Mar; 57(4):. PubMed ID: 33810477
    [No Abstract]   [Full Text] [Related]  

  • 40. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.